Back to search
FDAFDA · Food and drugs·Recall number D-1023-2013

PGE-1, 20 mcg/mL Injection in Normal Saline, 10 mL, University Compounding Pharmacy, 855-398-1800.

Published September 18, 2013 · Recall initiated: September 6, 2013

Summary

FDA records drug Class II recall D-1023-2013, published September 18, 2013 and initiated September 6, 2013. Recalling firm: University Compounding Pharmacy; Status: Terminated; Reported quantity: 85 mL; Lot: Lot #: 497940, Exp 9/6/2013. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Lack of Assurance of Sterility: University Compounding Pharmacy is voluntarily recalling certain pharmacy products due to lack of assurance of sterility concerns.

What to do

Voluntary: Firm initiated · Press Release

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
University Compounding Pharmacy
Distributor
Nationwide
Lot
Lot #: 497940, Exp 9/6/2013
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was PGE-1, 20 mcg/mL Injection in Normal Saline, 10 mL, University Compounding Pharmacy, 855-398-1800. recalled?

Yes. FDA published recall D-1023-2013 on September 18, 2013. Reported hazard: Lack of Assurance of Sterility: University Compounding Pharmacy is voluntarily recalling certain pharmacy products due to lack of assurance of sterility concerns.

What should I do if I have this product?

Voluntary: Firm initiated · Press Release